Literature DB >> 31588745

Ni-Catalyzed Asymmetric Allylation of Secondary Phosphine Oxides.

Xu-Teng Liu1, Ya-Qian Zhang1, Xue-Yu Han1, Shi-Ping Sun1, Qing-Wei Zhang1.   

Abstract

A nickel-catalyzed asymmetric allylation of secondary phosphine oxides (SPO) for the synthesis of tertiary phosphine oxides (TPO) was realized with high enantioselectivity. The dynamic kinetic asymmetric transformation of SPO was accomplished in the presence of nickel complex. By elucidating the absolute configurations of the reacted SPO starting material and the TPO product, we confirmed that the allylation reaction proceeded through a P-stereo retention process. The protocol represents the first example of synthesizing P-stereogenic phosphine oxides by allylation reaction.

Entities:  

Year:  2019        PMID: 31588745     DOI: 10.1021/jacs.9b08734

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Direct visible-light-induced synthesis of P-stereogenic phosphine oxides under air conditions.

Authors:  Ying Zhang; Jia Yuan; Guanglong Huang; Hong Yu; Jinpeng Liu; Jian Chen; Sixuan Meng; Jian-Ji Zhong; Li Dang; Guang-Ao Yu; Chi-Ming Che
Journal:  Chem Sci       Date:  2022-04-25       Impact factor: 9.969

2.  Nickel/Brønsted acid dual-catalyzed regio- and enantioselective hydrophosphinylation of 1,3-dienes: access to chiral allylic phosphine oxides.

Authors:  Jiao Long; Yuqiang Li; Weining Zhao; Guoyin Yin
Journal:  Chem Sci       Date:  2021-12-28       Impact factor: 9.825

3.  Ni-catalyzed asymmetric hydrophosphinylation of conjugated enynes and mechanistic studies.

Authors:  Ya-Qian Zhang; Xue-Yu Han; Yue Wu; Peng-Jia Qi; Qing Zhang; Qing-Wei Zhang
Journal:  Chem Sci       Date:  2022-03-10       Impact factor: 9.825

4.  Access to P-chiral sec- and tert-phosphine oxides enabled by Le-Phos-catalyzed asymmetric kinetic resolution.

Authors:  Haile Qiu; Qiang Dai; Jiafeng He; Wenbo Li; Junliang Zhang
Journal:  Chem Sci       Date:  2020-09-02       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.